A Phenolic Fraction from Catharanthus roseus L. Stems Decreases Glycemia and Stimulates Insulin Secretion

Abstract EN

Catharanthus roseus (L.) G.

(C.

roseus) is a medicinal plant used traditionally for diabetes mellitus control.

Several compounds of an alkaloidal nature have been proposed as hypoglycemic principles.

However, little attention has been paid to other compounds in this plant that could also participate in this hypoglycemic activity.

This study aimed to analyze the hypoglycemic effect of a polyphenolic fraction from C.

roseus, as well as its action on insulin secretion and expression in RINm5F cells.

Methods.

An alkaloid-free aqueous extract was obtained from C.

roseus stems.

The hypoglycemic effect of different doses of this extract was evaluated in normal and streptozotocin-induced diabetic mice.

This extract was fractionated by bipartition, and the resultant fractions were assessed by their hypoglycemic effects.

Subsequently, the fraction with the greater hypoglycemic activity was added to the RINm5F cells, and the expression and secretion of insulin were analyzed.

The antioxidant activity was determined by the DPPH method and through chromatographic analysis of the most active fraction by HPLC, using an Econosphere C18 column.

Results.

The aqueous alkaloid-free extract of C.

roseus stems significantly reduced blood glucose in normal and diabetic mice.

The fractionation of this extract provided three fractions, one of which (a precipitate) showed significant reductions in glycemia at 6 h (48.1 and 64.5% in normal and diabetic mice, respectively).

This precipitate contained phenolic compounds and saponins.

Its chromatographic analysis showed that it is formed by several phenolic compounds; gallic acid (0.053%) and chlorogenic acid (0.216%) were identified and quantified.

Conclusion.

The phenolic fraction of C.

roseus containing gallic acid and chlorogenic acid had a hypoglycemic effect that may be explained by an increase in insulin secretion.